Search research articles
Contact Us
Filters
Showing results (501-510 of 606) with videos related to
Page
of 61
Sort By:
Archives of General Psychiatry
|
August 4, 2010
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, et al.
Biological Psychiatry
|
February 25, 2023
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability
Marjorie R Levinstein, Meghan L Carlton, Tommaso Di Ianni, et al.
Neuroscience and Biobehavioral Reviews
|
January 4, 2025
Temporal dynamics of affective scene processing in the healthy adult human brain
Abigail O Vogeley, Alicia A Livinski, Shahaboddin Dabaghi Varnosfaderani, et al.
Journal of Mood and Anxiety Disorders
|
August 28, 2025
Clinical decision support for pharmacologic management of treatment-resistant depression with augmented large language models
Roy H Perlis, Pilar F Verhaak, Joseph Goldberg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 8, 2014
BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial
André R Brunoni, Rodrigo Machado-Vieira, Carlos A Zarate, et al.
The Journal of Clinical Psychiatry
|
May 2, 2024
A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder
Gregory H Jones, Courtney M Vecera, Ana C Ruiz, et al.
Molecular Psychiatry
|
November 17, 2019
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
Bashkim Kadriu, Cristan A Farmer, Peixiong Yuan, et al.
Neural Plasticity
|
July 3, 2015
Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
Annie J Xu, Mark J Niciu, Nancy B Lundin, et al.
Journal of Clinical Psychopharmacology
|
March 31, 2018
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability
Bashkim Kadriu, Shiwen Yuan, Cristan Farmer, et al.
Journal of Affective Disorders
|
May 17, 2023
Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database
Christoph Kraus, Alexander Kautzky, Victoria Watzal, et al.
Page
of 61
Search research articles
Search
Showing results (501-510 of 606) with videos related to
Sort By:
Page
of 61
Archives of General Psychiatry
|
August 4, 2010
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, et al.
Biological Psychiatry
|
February 25, 2023
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability
Marjorie R Levinstein, Meghan L Carlton, Tommaso Di Ianni, et al.
Neuroscience and Biobehavioral Reviews
|
January 4, 2025
Temporal dynamics of affective scene processing in the healthy adult human brain
Abigail O Vogeley, Alicia A Livinski, Shahaboddin Dabaghi Varnosfaderani, et al.
Journal of Mood and Anxiety Disorders
|
August 28, 2025
Clinical decision support for pharmacologic management of treatment-resistant depression with augmented large language models
Roy H Perlis, Pilar F Verhaak, Joseph Goldberg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 8, 2014
BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial
André R Brunoni, Rodrigo Machado-Vieira, Carlos A Zarate, et al.
The Journal of Clinical Psychiatry
|
May 2, 2024
A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder
Gregory H Jones, Courtney M Vecera, Ana C Ruiz, et al.
Molecular Psychiatry
|
November 17, 2019
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
Bashkim Kadriu, Cristan A Farmer, Peixiong Yuan, et al.
Neural Plasticity
|
July 3, 2015
Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
Annie J Xu, Mark J Niciu, Nancy B Lundin, et al.
Journal of Clinical Psychopharmacology
|
March 31, 2018
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability
Bashkim Kadriu, Shiwen Yuan, Cristan Farmer, et al.
Journal of Affective Disorders
|
May 17, 2023
Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database
Christoph Kraus, Alexander Kautzky, Victoria Watzal, et al.
Page
of 61